Academic Journal
Data on migration of the non-invasive breast cancer cell line, MCF-7 treated with Bevacizumab using Real Time Cell Analyzer (RTCA)
| Title: | Data on migration of the non-invasive breast cancer cell line, MCF-7 treated with Bevacizumab using Real Time Cell Analyzer (RTCA) |
|---|---|
| Authors: | Layal EL-Hajjar, Abdullah Shaito, Nour Jalaleddine, Kazem Zibara, Jalal M. Kazan, Jamal El-Saghir, Marwan El-Sabban |
| Source: | Data in Brief, Vol 22, Iss , Pp 635-638 (2019) |
| Publisher Information: | Elsevier, 2019. |
| Publication Year: | 2019 |
| Collection: | LCC:Computer applications to medicine. Medical informatics LCC:Science (General) |
| Subject Terms: | Computer applications to medicine. Medical informatics, R858-859.7, Science (General), Q1-390 |
| More Details: | Bevacizumab or Avastin® (Av), the recombinant antibody targeting VEGF, improves progression-free but not overall survival of metastatic breast cancer patients due to development of Av resistance. We showed that Av-therapy-induced inflammatory microenvironment contributes to the refractoriness to Av treatment. Here we present data regarding the effect of Av treatment on migration of a non-invasive breast cancer cell line, MCF-7. The data presented hereis related to the research article “Bevacizumab induces inflammation in MDA-MB-231 breast cancer cell line and in a mouse model” (Hajjar et al., 2018). Keywords: Bevacizumab, MCF-7, Migration, RTCA |
| Document Type: | article |
| File Description: | electronic resource |
| Language: | English |
| ISSN: | 2352-3409 |
| Relation: | http://www.sciencedirect.com/science/article/pii/S2352340918315981; https://doaj.org/toc/2352-3409 |
| DOI: | 10.1016/j.dib.2018.12.059 |
| Access URL: | https://doaj.org/article/33e7114a9460458e83134242ea4591c2 |
| Accession Number: | edsdoj.33e7114a9460458e83134242ea4591c2 |
| Database: | Directory of Open Access Journals |
| ISSN: | 23523409 |
|---|---|
| DOI: | 10.1016/j.dib.2018.12.059 |
| Published in: | Data in Brief |
| Language: | English |